306 related articles for article (PubMed ID: 1804896)
21. Concepts behind the development of multiple drug therapy regimens in leprosy.
Waters MF
Lepr Rev; 1986 Dec; 57 Suppl 1():61-7. PubMed ID: 3295437
[No Abstract] [Full Text] [Related]
22. Relapses during long-term follow up with drug-susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regimens; case reports.
Thomas A; Hari L; Nagarajan M; Prabhakar R
Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):391-4. PubMed ID: 7594922
[TBL] [Abstract][Full Text] [Related]
23. Multi-drug therapy of leprosy.
Ramu G
Indian J Lepr; 1985; 57(3):465-82. PubMed ID: 2420903
[No Abstract] [Full Text] [Related]
24. Leprosy at a turning point?
Harboe M
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):312-8. PubMed ID: 11221095
[No Abstract] [Full Text] [Related]
25. A quantitative basis for sustainable anti-Mycobacterium leprae chemotherapy in leprosy control programs.
Almeida JG
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):255-68. PubMed ID: 1522367
[No Abstract] [Full Text] [Related]
26. Distinguishing between relapse and late reversal reaction in multidrug (MDT)-treated BT leprosy.
Waters MF
Lepr Rev; 2001 Sep; 72(3):250-3. PubMed ID: 11715270
[No Abstract] [Full Text] [Related]
27. Dapsone drug resistance in the MDT era.
Roche PW; Neupane KD; Failbus SS; Butlin CR
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
[No Abstract] [Full Text] [Related]
28. Four-year follow-up results of a WHO-recommended multiple-drug regimen in paucibacillary leprosy patients in Malawi.
Boerrigter G; Pönnighaus JM; Fine PE; Wilson RJ
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):255-61. PubMed ID: 2071983
[TBL] [Abstract][Full Text] [Related]
29. Drug resistance and multi-drug therapy in leprosy.
Chatterjee BR
Lepr India; 1982 Jul; 54(3):402-11. PubMed ID: 6757576
[No Abstract] [Full Text] [Related]
30. Viability and drug susceptibility testing of M. leprae using mouse footpad in 37 relapse cases of leprosy.
Shetty VP; Wakade AV; Ghate S; Pai VV; Ganapati R; Antia NH
Int J Lepr Other Mycobact Dis; 2003 Sep; 71(3):210-7. PubMed ID: 14608816
[TBL] [Abstract][Full Text] [Related]
31. Multidrug therapy (MDT) and leprosy control.
Noordeen SK
Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680
[No Abstract] [Full Text] [Related]
32. Progress in the chemotherapy of leprosy.
Grosset JH
Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):268-77. PubMed ID: 8046266
[No Abstract] [Full Text] [Related]
33. Two microbiological relapses in a patient with lepromatous leprosy.
Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
[TBL] [Abstract][Full Text] [Related]
34. Clinical assessment of paucibacillary leprosy under multidrug therapy-three years followup study.
Revankar CR; Karjivkar VG; Gurav VJ; Ganapati R
Indian J Lepr; 1989 Jul; 61(3):355-9. PubMed ID: 2768883
[TBL] [Abstract][Full Text] [Related]
35. Comment: Persistence of Mycobacterium leprae in the peripheral nerves of multidrug-treated leprosy patients.
Grange JM; Beck JS; Abbot NC
Lepr Rev; 1993 Sep; 64(3):280. PubMed ID: 8110236
[No Abstract] [Full Text] [Related]
36. Allocation of patients to paucibacillary or multibacillary drug regimens for the treatment of leprosy--a comparison of methods based mainly on skin smears as opposed to clinical methods--alternative clinical methods for classification of patients.
Becx-Bleumink M
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):292-303. PubMed ID: 2071986
[TBL] [Abstract][Full Text] [Related]
37. Search for effective short-course regimens for the treatment of leprosy.
Pattyn SR
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):76-81. PubMed ID: 8326183
[No Abstract] [Full Text] [Related]
38. Drug resistance in leprosy.
Ghosh S
Indian J Dermatol; 1980 Jul; 25(3):1-4. PubMed ID: 7026426
[No Abstract] [Full Text] [Related]
39. Therapeutic prospects for paucibacillary leprosy.
Katoch K
Indian J Lepr; 2000; 72(3):351-61. PubMed ID: 11105276
[No Abstract] [Full Text] [Related]
40. The difficult decision when to discontinue multidrug therapy in leprosy.
Kato L
Acta Leprol; 1987; 5(4):279-82. PubMed ID: 3327350
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]